Aaron M Allen1, Yasmin Korzets Ceder2, Tzippy Shochat2, Eyal Fenig2, Aron Popovtzer2, Dimitry Bragilofsky2, Adi Alfassy2, Helena Allon2. 1. Department of Radiotherapy, Davidoff Center Rabin Medical Center and Sackler Faculty of Medicine Tel Aviv University, 49 Jabotinksi St, 49100, Petach Tikvah, Israel. Ahron.alon@gmail.com. 2. Department of Radiotherapy, Davidoff Center Rabin Medical Center and Sackler Faculty of Medicine Tel Aviv University, 49 Jabotinksi St, 49100, Petach Tikvah, Israel.
Abstract
PURPOSE: Limiting the heart dose in left sided breast cancer radiotherapy is critical. We sought to study the effect of using CPAP (continuous positive airway pressure) as an aid in reducing heart dose in breast cancer radiotherapy. METHODS: Patients with left sided breast cancer receiving adjuvant radiotherapy were enrolled on a prospective IRB (institutional review board) approved clinical trial utilizing CPAP during radiotherapy. Each patient was simulated and planned with and without CPAP and the best dosimetric results determined the patient's treatment. Data on the differences in lung and heart volume and position as well as boost cavity position with and without CPAP were analyzed. RESULTS: Twenty-four women from 10/16 to 10/18 were enrolled. Seven patients were not treated on study; only two of these were due to treatment issues. Median age was 54 years. 70% had breast only radiation and 30% were treated to breast\CW (chest wall) and regional nodes. The median lung volume with CPAP was 60% larger than without CPAP. (1637 vs. 996 cc) p < 0.001. The median heart volume decreased 12% with CPAP. (338 vs. 382 cc) In regards to the DVH, CPAP decreased mean heart dose from 3.02 to 1.6Gy (p = .0075) and V20 of the lungs from 17.1 to 13.8 with CPAP but this was not significant. CONCLUSION: CPAP assisted radiotherapy was tolerable and produced superior treatment plans in left sided breast cancer. This method is worthy of further investigation as a method to normal tissue sparing treatment of left sided breast cancer patients.
PURPOSE: Limiting the heart dose in left sided breast cancer radiotherapy is critical. We sought to study the effect of using CPAP (continuous positive airway pressure) as an aid in reducing heart dose in breast cancer radiotherapy. METHODS:Patients with left sided breast cancer receiving adjuvant radiotherapy were enrolled on a prospective IRB (institutional review board) approved clinical trial utilizing CPAP during radiotherapy. Each patient was simulated and planned with and without CPAP and the best dosimetric results determined the patient's treatment. Data on the differences in lung and heart volume and position as well as boost cavity position with and without CPAP were analyzed. RESULTS: Twenty-four women from 10/16 to 10/18 were enrolled. Seven patients were not treated on study; only two of these were due to treatment issues. Median age was 54 years. 70% had breast only radiation and 30% were treated to breast\CW (chest wall) and regional nodes. The median lung volume with CPAP was 60% larger than without CPAP. (1637 vs. 996 cc) p < 0.001. The median heart volume decreased 12% with CPAP. (338 vs. 382 cc) In regards to the DVH, CPAP decreased mean heart dose from 3.02 to 1.6Gy (p = .0075) and V20 of the lungs from 17.1 to 13.8 with CPAP but this was not significant. CONCLUSION: CPAP assisted radiotherapy was tolerable and produced superior treatment plans in left sided breast cancer. This method is worthy of further investigation as a method to normal tissue sparing treatment of left sided breast cancerpatients.
Entities:
Keywords:
Breast Cancer; CPAP; Cardiac toxicity; Radiotherapy
Authors: Harriet Eldredge-Hindy; Virginia Lockamy; Albert Crawford; Virginia Nettleton; Maria Werner-Wasik; Joshua Siglin; Nicole L Simone; Kulbir Sidhu; Pramila R Anne Journal: Pract Radiat Oncol Date: 2015 Jan-Feb
Authors: Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod Journal: J Clin Sleep Med Date: 2019-02-15 Impact factor: 4.062
Authors: Judit Boda-Heggemann; Antje-Christin Knopf; Anna Simeonova-Chergou; Hansjörg Wertz; Florian Stieler; Anika Jahnke; Lennart Jahnke; Jens Fleckenstein; Lena Vogel; Anna Arns; Manuel Blessing; Frederik Wenz; Frank Lohr Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-17 Impact factor: 7.038
Authors: Milly Buwenge; Silvia Cammelli; Ilario Ammendolia; Giorgio Tolento; Alice Zamagni; Alessandra Arcelli; Gabriella Macchia; Francesco Deodato; Savino Cilla; Alessio G Morganti Journal: Breast Cancer (Dove Med Press) Date: 2017-03-06
Authors: Heejoo Ko; Jee Suk Chang; Jin Young Moon; Won Hee Lee; Chirag Shah; Jin Sup Andy Shim; Min Cheol Han; Jong Geol Baek; Ryeong Hwang Park; Yong Bae Kim; Jin Sung Kim Journal: Front Oncol Date: 2021-04-12 Impact factor: 6.244
Authors: Evan Liang; Jennifer L Dolan; Eric D Morris; Jonathan Vono; Luisa F Bazan; Mei Lu; Carri K Glide-Hurst Journal: Adv Radiat Oncol Date: 2022-01-04